AEMD Aethlon Medical, Inc. Stock Quote

AEMD [NASD]

Index	-	P/E	-	EPS (ttm)	-0.79	Insider Own	0.80%	Shs Outstand	12.07M	Perf Week	-6.27%
Market Cap	28.88M	Forward P/E	-	EPS next Y	-0.63	Insider Trans	-22.79%	Shs Float	11.78M	Perf Month	56.79%
Income	-5.80M	PEG	-	EPS next Q	-0.17	Inst Own	10.40%	Short Float	3.89%	Perf Quarter	59.75%
Sales	0.60M	P/S	48.13	EPS this Y	63.60%	Inst Trans	-	Short Ratio	0.23	Perf Half Y	21.53%
Book/sh	1.14	P/B	2.23	EPS next Y	21.80%	ROA	-49.70%	Target Price	-	Perf Year	103.20%
Cash/sh	1.28	P/C	1.99	EPS next 5Y	-	ROE	-54.60%	52W Range	1.18 - 4.34	Perf YTD	2.83%
Dividend	-	P/FCF	-	EPS past 5Y	36.60%	ROI	-67.80%	52W High	-41.47%	Beta	0.66
Dividend %	-	Quick Ratio	9.90	Sales past 5Y	-3.10%	Gross Margin	-	52W Low	115.25%	ATR	0.23
Employees	8	Current Ratio	9.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	58.48	Volatility	6.61% 11.05%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	88.70%	Profit Margin	-	Rel Volume	0.13	Prev Close	2.62
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 28 AMC	Payout	-	Avg Volume	1.98M	Price	2.54
Recom	2.00	SMA20	6.39%	SMA50	32.66%	SMA200	52.09%	Volume	257,072	Change	-3.05%

Jan-06-21 08:02AM	Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer PR Newswire -8.21%
Jan-04-21 08:02AM	Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire
Dec-16-20 08:02AM	Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer PR Newswire +39.51%
Nov-03-20 08:01AM	Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer PR Newswire
Oct-29-20 11:45AM	AEMD: Oncology EFS Open For Enrollment Zacks Small Cap Research
Oct-28-20 04:15PM	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update PR Newswire -8.00%
02:30PM	Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
07:41AM	The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts Benzinga
Oct-19-20 08:01AM	Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020 PR Newswire
Oct-13-20 10:30AM	AEMD: Advancing The Hemopurifier in Two Feasibility Studies Zacks Small Cap Research +33.11%
Sep-09-20 08:01AM	Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference PR Newswire
Aug-27-20 08:01AM	Aethlon Medical to Present at the LD Micro 500 Virtual Conference PR Newswire
Aug-11-20 04:15PM	Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update PR Newswire -5.50%
06:33AM	We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate Simply Wall St.
06:28AM	We Think Aethlon Medical (NASDAQ:AEMD) Needs To Drive Business Growth Carefully Simply Wall St.
Aug-06-20 12:43AM	Edited Transcript of AEMD earnings conference call or presentation 25-Jun-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-25-20 04:15PM	Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update PR Newswire +6.22%
02:30PM	Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Jun-22-20 08:31AM	Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting PR Newswire -13.96%
Jun-18-20 12:49PM	FDA Backs Testing of Device Once Flagged for Covid Speculation Bloomberg +89.36%
09:19AM	Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients PR Newswire
Jun-16-20 08:30AM	Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020 PR Newswire
Mar-24-20 08:58AM	Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer PR Newswire -8.78%
Mar-06-20 12:08PM	AEMD: Coronavirus 2019 (COVID-19) Could Represent New Opportunity for AEMD Zacks Small Cap Research +7.62%
Feb-25-20 03:25PM	18 Medical Stocks To Watch Amid The Coronavirus Outbreak Benzinga -17.55%
Feb-24-20 10:22AM	Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires PR Newswire -5.04%
Feb-17-20 01:37PM	Edited Transcript of AEMD earnings conference call or presentation 10-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-13-20 05:35AM	Investors Who Bought Aethlon Medical (NASDAQ:AEMD) Shares Five Years Ago Are Now Down 98% Simply Wall St.
Feb-10-20 04:15PM	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update PR Newswire
09:01AM	Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock PR Newswire
Feb-06-20 08:01AM	Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020 PR Newswire
Jan-23-20 01:02PM	13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
09:51AM	The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech Zacks
Jan-22-20 02:28PM	Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance +14.29%
01:16PM	Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering PR Newswire
08:12AM	Coronavirus Infects Wall Street: Stocks to Gain & Lose Zacks
Jan-21-20 02:40PM	Experimental vaccine stocks jump on concerns about new virus in China MarketWatch +12.14%
Jan-17-20 08:49AM	Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire -25.36%
Dec-17-19 04:18PM	Aethlon Medical Announces Closing of $5 Million Public Offering PR Newswire -6.50%
Dec-13-19 07:00AM	Aethlon Medical Announces Pricing of $5 Million Public Offering PR Newswire -47.85%
Nov-15-19 05:04AM	Here's Why We Worry About Aethlon Medical's (NASDAQ:AEMD) Cash Burn Situation Simply Wall St.
Nov-01-19 04:15PM	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update PR Newswire -10.00%
Oct-29-19 03:17PM	Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019 PR Newswire -15.42%
Oct-28-19 07:00AM	AEMD: IDE Approved. Hemopurifier U.S. Clinical Cancer Program On-Deck Zacks Small Cap Research
Oct-14-19 03:55PM	Aethlon Announces Reverse Stock Split PR Newswire

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shah Chetan	Director	Dec 17	Sale	2.11	26,852	56,580	16,641	Dec 18 05:00 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience